Used in neuroscience research to quantify levels of postsynaptic density protein 95 (PSD-95) in mouse brain tissue or neuronal cell samples. Helps assess synaptic integrity and density in studies related to neurodegenerative diseases, such as Alzheimer's, Parkinson's, and Huntington's disease. Widely applied in preclinical drug development to evaluate the effects of therapeutic compounds on synaptic health. Also utilized in research on neurodevelopmental disorders, including autism and schizophrenia, to understand synaptic protein expression changes. Provides a reliable, sensitive, and high-throughput method for detecting PSD-95 in experimental models of brain injury, stroke, and psychiatric conditions.